Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada · Delayed Price · Currency is CAD 0.1700
+0.0100 (6.25%)
Oct 30, 2026, 3:47 PM EDT
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of CAD 18.65 million as of October 30, 2026. It is the 39,631st most valuable company in the world and the 1,317th biggest in Canada. Its market cap has increased by 32.05% in one year.
Market Cap
18.65M
Enterprise Value
18.40M
Revenue
1.27M
Global Rank
Country Rank
#1,317 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 6.64M to 18.65M, an increase of 180.81%. That is a compound annual growth rate of 23.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 18.65M | 55.67% |
| Dec 31, 2025 | 11.98M | -53.64% |
| Dec 31, 2024 | 25.84M | 112.35% |
| Dec 29, 2023 | 12.17M | 486.37% |
| Dec 30, 2022 | 2.07M | -68.75% |
| Jan 11, 2022 | 6.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Defence Therapeutics | 26.53M |
| Resverlogix | 25.82M |
| Telescope Innovations | 24.65M |
| The More Life Company | 22.85M |
| Devonian Health Group | 21.52M |
| Onco-Innovations | 15.92M |
| Lobe Sciences | 15.28M |
| Rapid Dose Therapeutics | 14.47M |